In order to further improve the level of diagnosis and treatment of refractory hematological diseases and benefit patients from Sichuan and beyond, the municipal medical education activity "Diagnostic and Therapeutic Seminar on Refractory Hematological Diseases", sponsored by the Chengdu High-tech Medical Association and organized byngdu BOE Hospital, was successfully held on June 28, 2025, at the Academic Lecture Hall on the first floor of the research building ofngdu BOE Hospital. Experts and clinicians from the field of hematology from inside and outside the province gathered to have in-depth discussions on the cutting-edge progress clinical challenges in the diagnosis and treatment of refractory hematological diseases, injecting new impetus into the development of the industry

The opening ceremony of the conference was chaired by Professor Li Yecheng from Chengdu Jingdong Hospital, and Professor Niu Ting from China Hospital of Sichuan University and Vice President Wang Cunbang from Chengdu Jingdong Hospital attended the opening ceremony and delivered speeches.

Professor Niu Tings opening speech emphasized the importance of overcoming refractory hematologic diseases to improve the quality of life for patients, and fully affirmed the significance and necessity of this training. He also looked forward to promoting the development of hematological diagnosis and treatment through the conference exchange platform.

Vice President Wang Cunbang stated: The Hematology of Jingdong Hospital is committed to serving patients wholeheartedly, and this continuing education class can just provide a platform to enhance self-improvement and mutual exchange for this.

                The successful holding of this workshop on the diagnosis and treatment of refractory hematological diseases has not only built a high-quality academic exchange platform, but provided a strong support for the industry to share diagnosis and treatment experience and overcome technical problems. In the future, the Chengdu High-tech Medical Association will continue to work Chengdu BOE Hospital to focus on the field of hematology and carry out a series of academic activities, which will help to improve the overall level of diagnosis and treatment refractory hematological diseases in China.